⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TRAW News
Traws Pharma, Inc. Common Stock
Traws Pharma Provides Regulatory Update on Influenza Program
globenewswire.com
TRAW
Form 8-K
sec.gov
TRAW
Form 8-K
sec.gov
TRAW
Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks
globenewswire.com
TRAW
Form 8-K
sec.gov
TRAW
Form 8-K
sec.gov
TRAW
Traws Pharma Provides Business Highlights and Reports Q1 2026 Financial Results
globenewswire.com
TRAW
Traws Pharma to Advance Potential Clinical Candidates for the Treatment of Hantavirus Infections
globenewswire.com
TRAW
Form 8-K
sec.gov
TRAW
Traws Pharma Reports Full Year 2025 Results and Provides Business Highlights
globenewswire.com
TRAW